Neutral
MaxCyte (NASDAQ: MXCT) Q1 2026 revenue dips as expenses fall
MaxCyte (NASDAQ: MXCT) reported its Q1 2026 financial results, showing a decrease in revenue to $9.7 million from $10.4 million in the prior year, tho...
MXCT
--
--
--
--
Price Chart (30 Days)
Ad Space
Analyst Sentiment
Bullish (0)
Neutral (1)
Bearish (0)
Latest MXCT News
Research MXCT on:
Ad Space